MYT1L and metastatic malignant neoplasm in the lymph nodes: The contribution of MYT1L rs17039396 A allele to the improved survival of cardia gastric cancer patients were further evaluated by stratified analysis of tumor size, histological types, degree of differentiation, depth of invasion, lymph node metastasis, distant metastasis and TNM stage.